insights_auto
Why is CONCORDBIO down 2.02%?
Dive Deeperchevron_right
CONCORDBIO:NSE
Concord Biotech Ltd
₹1,354.20
arrow_downward
-2.02%(-27.90) 1D
Oct 15, 3:15:45 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CONCORDBIO...
Open
₹1,390.80
High
₹1,394.90
Low
₹1,350.00
Mkt. cap
141.66B
Avg. vol.
139.50K
Volume
34.53K
Dividend
0.56%
Quarterly dividend
₹1.89
Ex-dividend date
Jul 24, 2026
P/E ratio
51.47
52-wk high
₹1,615.00
52-wk low
₹987.00
EPS
₹26.31
No. of employees
2K
Open
₹1,390.80
High
₹1,394.90
Low
₹1,350.00
Mkt. cap
141.66B
Avg. vol.
139.50K
Volume
34.53K
Dividend
0.56%
Quarterly dividend
₹1.89
Ex-dividend date
Jul 24, 2026
P/E ratio
51.47
52-wk high
₹1,615.00
52-wk low
₹987.00
EPS
₹26.31
No. of employees
2K
News stories
From web sources and news partners
FXStreet
·
1 hour ago
Dow Jones futures gains ahead of US PPI, Retail Sales data
Barron's
·
46 minutes ago
The S&P 500’s Dividend Yield Is at an All-Time Low. Is That a Bad Sign?
TradingView
·
1 hour ago
Tech sector breaks uptrend, raising risk of further S&P 500 losses
Profile
Concord Biotech Limited is an Indian biotechnology company headquartered in Ahmedabad. The company manufactures fermentation-based biopharmaceutical active pharmaceutical ingredients sold worldwide.
It manufactures biopharmaceutical products across therapy segments such as immunosuppressant, oncology, antifungal, antibacterial and anthelmintic. It has two manufacturing facilities–at Dholka near Ahmedabad, which is approved by USFDA, and at Limbasi in Kheda district. Wikipedia
About Concord Biotech Ltd